Protalix BioTherapeutics, Inc. Gross Profit
Protalix BioTherapeutics, Inc. (PLX) reported Gross Profit of -$1.25 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2018-11-07
- Protalix BioTherapeutics, Inc. gross profit for the quarter ending 2018-09-30 was -$1.25M, a 185.89% decline year-over-year.
- Protalix BioTherapeutics, Inc. gross profit for the quarter ending 2018-06-30 was -$177.00K, a 121.20% decline year-over-year.
- Protalix BioTherapeutics, Inc. gross profit for the quarter ending 2018-03-31 was $1.63M, a 103.37% increase year-over-year.
- Protalix BioTherapeutics, Inc. gross profit for the quarter ending 2017-12-31 was $915.00K, a 609.30% increase year-over-year.
- Protalix BioTherapeutics, Inc. gross profit for fiscal 2017 was $4.01M, a 400.75% increase from fiscal 2016.
- Protalix BioTherapeutics, Inc. gross profit for fiscal 2016 was $801.00K, a 77.96% decline from fiscal 2015.
- Protalix BioTherapeutics, Inc. gross profit for fiscal 2015 was $3.63M, a 25.61% increase from fiscal 2014.
- Protalix BioTherapeutics, Inc. gross profit for fiscal 2014 was $2.89M.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | -$1.25M 10-Q · filed 2018-11-07 | -$1.43M derived: sum of 2 quarters · filed 2018-11-07 | $198.00K 10-Q · filed 2018-11-07 | $1.11M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2018-06-30 | -$177.00K 10-Q · filed 2018-08-09 | $1.45M 10-Q · filed 2018-08-09 | $2.37M derived: sum of 3 quarters · filed 2018-08-09 | $3.83M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2018-03-31 | $1.63M 10-Q · filed 2018-05-09 | $2.54M derived: sum of 2 quarters · filed 2018-05-09 | $4.00M derived: sum of 3 quarters · filed 2018-11-07 | $4.84M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $2.38M derived: sum of 2 quarters · filed 2018-11-07 | $3.21M derived: sum of 3 quarters · filed 2018-11-07 | $4.01M 10-K · filed 2018-03-06 | ||||
| 2017-09-30 | $1.46M 10-Q · filed 2018-11-07 | $2.29M derived: sum of 2 quarters · filed 2018-11-07 | $3.10M 10-Q · filed 2018-11-07 | $3.23M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $835.00K 10-Q · filed 2018-08-09 | $1.64M 10-Q · filed 2018-08-09 | $1.76M derived: sum of 3 quarters · filed 2018-08-09 | $2.19M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $801.00K 10-Q · filed 2018-05-09 | $930.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.35M derived: sum of 3 quarters · filed 2018-05-09 | $1.45M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $551.00K derived: sum of 2 quarters · filed 2018-03-06 | $645.00K derived: sum of 3 quarters · filed 2018-03-06 | $801.00K 10-K · filed 2018-03-06 | ||||
| 2016-09-30 | $422.00K 10-Q · filed 2017-11-08 | $516.00K derived: sum of 2 quarters · filed 2017-11-08 | $672.00K 10-Q · filed 2017-11-08 | $672.00K derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-06-30 | $94.00K 10-Q · filed 2017-08-09 | $250.00K 10-Q · filed 2017-08-09 | $250.00K derived: sum of 3 quarters · filed 2018-03-06 | $1.36M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-03-31 | $156.00K 10-Q · filed 2017-05-10 | $156.00K derived: sum of 2 quarters · filed 2018-03-06 | $1.27M derived: sum of 3 quarters · filed 2018-03-06 | $2.38M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $1.11M derived: sum of 2 quarters · filed 2018-03-06 | $2.22M derived: sum of 3 quarters · filed 2018-03-06 | $3.63M 10-K · filed 2018-03-06 | ||||
| 2015-09-30 | $1.11M 10-Q · filed 2016-11-09 | $3.50M 10-Q · filed 2015-11-09 | $2.22M derived: sum of 2 quarters · filed 2016-11-09 | $3.63M 10-Q · filed 2016-11-09 | $8.77M 10-Q · filed 2015-11-09 | $227.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $1.11M 10-Q · filed 2016-08-08 | $2.58M 10-Q · filed 2015-08-10 | $2.52M 10-Q · filed 2016-08-08 | $5.27M 10-Q · filed 2015-08-10 | -$886.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.02M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $1.41M 10-Q · filed 2016-05-09 | $2.70M 10-Q · filed 2015-05-07 | -$2.00M derived: sum of 2 quarters · filed 2017-03-16 | -$88.00K derived: sum of 3 quarters · filed 2017-03-16 | $993.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$1.50M derived: sum of 2 quarters · filed 2017-03-16 | -$417.00K derived: sum of 3 quarters · filed 2017-03-16 | $2.89M 10-K · filed 2017-03-16 | $6.11M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $1.91M 10-Q · filed 2015-11-09 | $2.99M derived: sum of 2 quarters · filed 2015-11-09 | $6.30M 10-Q · filed 2015-11-09 | -$215.00K derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-06-30 | $1.08M 10-Q · filed 2015-08-10 | $4.39M 10-Q · filed 2015-08-10 | -$2.12M derived: sum of 3 quarters · filed 2016-03-08 | -$352.00K derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-03-31 | $3.31M 10-Q · filed 2015-05-07 | -$3.21M derived: sum of 2 quarters · filed 2016-03-08 | -$1.43M derived: sum of 3 quarters · filed 2016-03-08 | $313.00K derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2013-12-31 | -$6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$4.74M derived: sum of 2 quarters · filed 2016-03-08 | -$3.00M derived: sum of 3 quarters · filed 2016-03-08 | $0.00 10-K · filed 2016-03-08 | $6.08M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $1.77M 10-Q · filed 2014-11-10 | $3.52M derived: sum of 2 quarters · filed 2014-11-10 | $6.51M 10-Q · filed 2014-11-10 | $5.38M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $1.75M 10-Q · filed 2014-08-07 | $4.74M 10-Q · filed 2014-08-07 | $3.61M derived: sum of 3 quarters · filed 2015-03-12 | $6.64M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $3.00M 10-Q · filed 2014-05-08 | $1.87M derived: sum of 2 quarters · filed 2015-03-12 | $4.89M derived: sum of 3 quarters · filed 2015-03-12 | $26.87M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.89M derived: sum of 2 quarters · filed 2015-03-12 | $23.87M derived: sum of 3 quarters · filed 2015-03-12 | $26.28M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $3.02M 10-Q · filed 2013-11-07 | $25.00M derived: sum of 2 quarters · filed 2013-11-07 | $27.41M 10-Q · filed 2013-11-07 | $27.70M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $21.98M 10-Q · filed 2013-08-08 | $24.39M 10-Q · filed 2013-08-08 | $24.68M derived: sum of 3 quarters · filed 2014-03-13 | $25.36M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $2.41M 10-Q · filed 2013-05-09 | $2.70M derived: sum of 2 quarters · filed 2014-03-13 | $3.38M derived: sum of 3 quarters · filed 2014-03-13 | -$1.37M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $971.00K derived: sum of 2 quarters · filed 2014-03-13 | -$3.78M derived: sum of 3 quarters · filed 2014-03-13 | $1.44M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $677.00K 10-Q · filed 2012-11-07 | -$4.07M derived: sum of 2 quarters · filed 2012-11-07 | $1.15M 10-Q · filed 2012-11-07 | $4.43M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$4.75M 10-Q · filed 2012-08-03 | $472.00K 10-Q · filed 2012-08-03 | $3.75M derived: sum of 3 quarters · filed 2013-02-28 | $5.87M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $5.22M 10-Q · filed 2012-05-09 | $8.50M derived: sum of 2 quarters · filed 2013-02-28 | $10.62M derived: sum of 3 quarters · filed 2013-02-28 | $11.24M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $5.40M derived: sum of 2 quarters · filed 2013-02-28 | $6.01M derived: sum of 3 quarters · filed 2013-02-28 | $6.86M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $2.12M 10-Q · filed 2011-11-07 | $2.73M derived: sum of 2 quarters · filed 2011-11-07 | $3.58M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $613.00K 10-Q · filed 2011-08-08 | $1.46M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | -$3.19M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |